• Skip to primary navigation
  • Skip to main content

Mackenzie's Mission HomepageMackenzie's Mission

DONATE Mackenzies Mission Donate
  • Mission
  • About
    • The Story
    • Board
  • Resources
    • Resource List
    • What Is Amyloidosis
  • Speakers Bureau
    • About ASB
    • ASB Operating Committee
  • Fundraisers
  • Blog
  • Contact

"What lies behind you and what lies in front of you, pales in comparison to what lies inside of you."
Ralph Waldo Emerson

Blog

Heart Failure & Amyloidosis

October 27, 2022

Heart failure occurs when the heart muscle doesn’t pump blood as well as it should. Many medical conditions that damage the heart muscle can cause heart failure, such as Coronary artery disease, Heart attack, Obesity, Kidney disease, Diabetes, and Cardiomyopathy. Here we summarize how cardiac amyloidosis is associated with heart failure.

Filed Under: Featured News, What Is Amyloidosis Tagged With: Amyloid cardiomyopathy, amyloidosis, amyloidosis diagnosis, ATTR amyloidosis, ATTR-CM, cardiac amyloidosis, cardiomyopathy, diagnosing amyloidosis, heart failure

Over 10,000 medical students and residents!!

October 25, 2022

The Amyloidosis Speakers Bureau has now presented to over 10,000 medical students and residents!

Filed Under: Featured News, Speakers Bureau News Tagged With: #amyloidosisspeakersbureau, amyloidosis, patientsteachingstudents

Int’l Symposium on Amyloidosis (ISA) – Heidelberg 2022

September 12, 2022

We are super proud to have presented the story about the Amyloidosis Speakers Bureau at last week’s International Symposium on Amyloidosis (ISA) in Heidelberg, Germany. 

Filed Under: Featured News, Speakers Bureau News Tagged With: amyloidosis, amyloidosis diagnosis, amyloidosis news, amyloidosis speakers bureau, diagnosing amyloidosis, patientsteachingstudents, speakers bureau news

FDA Drug Approval Process

August 24, 2022

Drugs are the lifeblood of patient treatments, and the development of new drugs is critical. Overseen by the FDA (U.S. Food and Drug Administration), in this blog we outline the phases and 12 steps required to develop and approve drugs.

Filed Under: Featured News, What Is Amyloidosis Tagged With: amyloidosis, amyloidosis clinical trials, amyloidosis research, amyloidosis research consortium, Boston medical center, clinical trials, FDA drug approval, mayo clinic, my amyloidosis pathfinder, what is a clinical trial

Carpal Tunnel & Amyloidosis – An Update

July 27, 2022

In the amyloidosis community, we are quickly learning that carpal tunnel syndrome can be one of the earliest symptoms/indicators of amyloidosis, sometimes presenting up to a decade before diagnosis. In addition, it is suspected that amyloidosis is not as rare as we once thought. Interestingly, carpal tunnel release surgery is helping to illustrate just that.

Filed Under: Featured News, What Is Amyloidosis Tagged With: amyloidosis, amyloidosis diagnosis, amyloidosis research, ATTR amyloidosis, ATTRwt, cardiac amyloidosis, hATTR, raising awareness, wild-type amyloidosis

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 19
  • Go to Next Page »

Be A Part Of Our Mission!

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

  • Mission
  • About
  • Resources
  • Speakers Bureau
  • Fundraisers
  • Blog
  • Contact

Registered 501(c)(3) · Contact · Copyright © 2023 · Mackenzies Mission - All Rights Reserved